A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Clinical trial NCT06234605 · RECRUITING

Trial details

NCT number: NCT06234605
Sponsor: HiberCell, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2024-04-29
Primary completion: 2026-11-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.